Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

Journal of Clinical Trials : Citations & Metrics Report

Articles published in Journal of Clinical Trials have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Trials has got h-index 22, which means every article in Journal of Clinical Trials has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical Trials.

Journal total citations count 1734
Journal impact factor 2.76
Journal 5 years impact factor 3.07
Journal cite score 3.14
Journal h-index 22
Journal h-index since 2019 16
Important citations (609)

immuno-oncology: commiserating the function and abortive of the immune system in cancer: a review

The development of treatment of gastric cancer with liver metastasis

Effects of thermal ablation on treg/th17 in hepatocellular carcinoma of mice

Advanced hepatocellular carcinoma treated by radiofrequency ablation combined with oncolytic virus and anti-pd-1 antibody therapy: a case report and literature review

Evaluation of microwave ablation efficacy by strain elastography and shear wave elastography in ex vivo porcine liver.

immunological markers, prognostic factors and challenges following curative treatments for hepatocellular carcinoma

Immunological markers, prognostic factors and challenges following curative treatments for hepatocellular carcinoma

Sunitinib and sorafenib modulating antitumor immunity in hepatocellular cancer

Long-term survival of a patient with advanced pancreatic cancer under adjunct treatment with viscum album extracts: a case report

development of incvax, in situ cancer vaccine, and its immune response in mice with hepatocellular cancer

Hepatic thermal injury promotes colorectal cancer engraftment in c57/black 6 mice

Hepatic thermal injury promotes colorectal cancer engraftment in c57/black 6 mice

Microwave or radiofrequency ablation: clinically equivalent

image-guided locoregional non-intravascular interventional treatments for hepatocellular carcinoma: current status

Immuno-oncology and its opportunities for interventional radiologists: immune checkpoint inhibition and potential synergies with interventional oncology procedures

Imbrave 050: a phase iii trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation

Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: a systematic review and meta-analysis.

Developing a roadmap for interventional oncology

Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy

Breast cancer and use of alternative medicine: a mini review

Top